Health

Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire announcement issued today indicating that Opiant Pharmaceuticals and Hikma have entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.     About Hikma Hikma Pharmaceuticals PLC (LSE: HIK) […]

thaipr.net

3 พ.ค. 65

Esaote Group: the Shareholders’ Meeting approves the financial statements as at 31 December 2021, with consolidated turnover of 231.3 million euros (+5.3%) and an increase in net profit to 4 million euros.

Operating income was 9.4 million euros (+2.9%) and the gross operating margin stood at 32.2 million euros. The total order book for magnetic resonance imaging and ultrasound rose by 19%. Esaote confirms its strong vocation for international markets (70%): growth was notable in North America, China, and Western Europe. Italy is the leading market. The […]

thaipr.net

3 พ.ค. 65

The Danish National Genome Center Partners with Lifebit to Deliver Nationwide Personalised Medicine

The Danish National Genome Center has awarded Lifebit a four-year contract to implement Lifebit’s Federated Trusted Research Environment software, Lifebit CloudOS, within Denmark’s national supercomputing center. Lifebit, whose leading technology enables secure analysis over sensitive datasets for researchers and interconnects such large patient cohorts worldwide, today announces a long-term partnership with the Danish National…

thaipr.net

29 เม.ย. 65

Zimmer Biomet’s mymobility is recognized as “The Care Management Initiative of the Year” by the 2022 Healthcare Asia Medtech Awards

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that the company’s mymobility® digital care management platform won “The Care Management Initiative of the Year” award at this year’s Healthcare Asia Medtech Awards. mymobility® is a digital care management platform that uses iPhone® and Apple Watch® or Android devices […]

thaipr.net

28 เม.ย. 65

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct Biologics is the first and only EV […]

thaipr.net

27 เม.ย. 65
1 … 83 84 85 86 87 … 139

Copyright © 2026 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.